Keyon Lab combines complementary expertise across the entire early drug discovery process, integrating computational design, medicinal chemistry, experimental pharmacology, and translational biology.
Our platform includes:
- Rational drug design and medicinal chemistry
- Structure-based molecular modeling
- Electrophysiological characterization of ion channels
- Patient-derived cellular disease models
- Preclinical pharmacology and efficacy studies
- Advanced biochemical studies (proteomic, lipidomic and transcriptomic)
- In vivo animal models predictive of human diseases
- Pharmacokinetic profiling
- Translational validation of therapeutic candidates
This multidisciplinary approach enables rapid optimization of lead compounds while reducing development risk and accelerating progression toward clinical translation.